Clinical Effectiveness of Biomaterials in Indirect Pulp Therapy Treatment of Young Permanent Molars with Deep Carious Lesions: A Case-Control Study.

Abstract

Aim: The present case-control study was planned to assess the comparative efficacy of resin-modified calcium silicate, resin-modified glass ionomer, and Dycal as pulp capping agents in indirect pulp therapy for deeply carious young permanent molars.

Materials and methods: Thirty deeply carious young posterior teeth were treated by indirect pulp therapy. During the treatment, the cavity floor was lined with TheraCal or resin-modified glass ionomer cement (RMGIC) in the study group and with Dycal (control group) followed by GC IX and composite restoration. The teeth were reviewed and evaluated clinically and radiographically after 6 and 12 months.

Results: None of the study subjects experienced pain in any of the three study groups up to 12 months. Maturogenesis was seen in all 30 study teeth. Maximum% gain in dentin formation was seen in group I (TheraCal), that is, 16.100 ± 2.42, followed by group II (RMGIC), that is, 11.6000 ± 1.42, and group III (Dycal), that is, 9.6000 ± 0.96, and the difference between group I and group II and group I and group III was highly significant (p < 0.0001). Dentin formation was observed earlier at 6 months in 82.5% of cases with mesio-occlusal (MO) cavities as compared to 62.5% of cases with disto-occlusal (DO) extension.

Conclusion: TheraCal LC may be preferred as a pulp capping agent in the management of deeply carious young permanent molars for better healing in less time.

How to cite this article: Altaf G, Garg S, Saraf BG, et al. Clinical Effectiveness of Biomaterials in Indirect Pulp Therapy Treatment of Young Permanent Molars with Deep Carious Lesions: A Case-Control Study. Int J Clin Pediatr Dent 2024;17(11):1199-1205.